PET-CT Based Radiotherapy in Esophageal Cancer Patients
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.
Esophageal Neoplasms
Locoregional control, 2 years and 5 years
Overall Survival, 2 years and 5 years|Disease Free survival, 2 years and 5 years|Tumor regression grade, Tumor regression grade at time of surgery evaluated by pathologist., At the time of surgery
The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients